- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier på Tilbakefallende myelomatose
Totalt 62346 resultater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
NYU Langone HealthNational Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Trombocytopeni | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende myelomatose | Refraktært myelomatose | DS stadium I multippelt myelom | DS stadium II multippelt myelom | DS stadium III multippelt myelomForente stater
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyFullførtResidiverende eller refraktært myelomatose | Tilbakefallende eller refraktær akutt myeloid leukemi | Tilbakefallende eller refraktær non-Hodgkin lymfom | Tilbakefallende eller refraktær kronisk lymfatisk leukemiStorbritannia, Spania, Frankrike, Australia
-
City of Hope Medical CenterFullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Ulmende myelomatose | Refraktært myelomatoseForente stater
-
University of ChicagoNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationAvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TilbaketrukketStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Mayo ClinicFullførtMultippelt myelom | Stage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Novartis PharmaceuticalsFullførtMultippel myelom beinsykdomStorbritannia, Forente stater
-
AGC Biologics S.p.A.Horizon 2020 - European CommissionAvsluttetAkutt myeloid leukemi | Multippelt myelomItalia, Tsjekkia
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeDS stadium I multippelt myelom | DS stadium II multippelt myelom | DS stadium III multippelt myelomForente stater
-
Ohio State University Comprehensive Cancer CenterFullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Mayo ClinicFullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeDS stadium I multippelt myelom | DS stadium II multippelt myelom | DS stadium III multippelt myelomForente stater, Saudi-Arabia, Puerto Rico
-
National Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater, Sør-Afrika
-
The Cleveland ClinicTilbaketrukketStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Ildfast plasmacelle-neoplasmaForente stater
-
National Cancer Institute (NCI)RekrutteringMultippelt myelom | Residiverende og/eller refraktært multippelt myelom (RRMM) | Nylig diagnostisert multippelt myelom (NDMM)Forente stater
-
Benovus Bio, Inc.UkjentMyelodysplastisk syndrom (MDS) | Akutt myelogen leukemi (AML) | Myelomatose (MM) | Ulmende myelomatose (sMM)Forente stater
-
Sun Yat-sen UniversityChina Food and Drug AdministrationTilbaketrukketTilbakefall/Refraktær MyelomKina
-
CASI Pharmaceuticals, Inc.FullførtTilbakefallende myelomatose | Platåfase multippelt myelomForente stater
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)FullførtStadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
GenmabRekrutteringAkutt myeloid leukemi (AML) | Diffust storcellet B-celle lymfom (DLBCL) | Residiverende eller refraktært multippelt myelom (RRMM)Forente stater, Korea, Republikken, Nederland, Danmark, Australia, New Zealand, Polen, Spania, Sverige, Tsjekkia, Malaysia, Hellas, Moldova, Republikken, Georgia, Ukraina, Frankrike, Ungarn, Nord-Makedonia, Bosnia og Herzegovina
-
Seoul St. Mary's HospitalAktiv, ikke rekrutterendeMyelom multippelKorea, Republikken
-
National Cancer Institute (NCI)AvsluttetStadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Centro de Atencion e Investigacion MedicaHar ikke rekruttert ennå
-
M.D. Anderson Cancer CenterRekruttering
-
PETHEMA FoundationAdknoma Health ResearchRekrutteringTilbakefallende myelomatoseSpania
-
Association for Training, Education, and Research...FullførtTilbakefallende myelomatoseFrankrike
-
UNC Lineberger Comprehensive Cancer CenterConquer Cancer FoundationFullførtMultippelt myelom | Myelom | Funksjonshemming Fysisk | Funksjonshemminger MultipleForente stater
-
Abramson Cancer Center at Penn MedicineRekruttering
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationAktiv, ikke rekrutterende
-
Centre Hospitalier Universitaire de Saint EtienneFullført
-
Nantes University HospitalUkjent
-
Oslo University HospitalRekruttering
-
Cristiana Costa Chase, DOHar ikke rekruttert ennåResidiverende/refraktært myelomatoseForente stater
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene... og andre samarbeidspartnereRekrutteringResidiverende refraktært myelomatoseForente stater
-
University of LeedsFullførtResidiverende eller refraktært myelomatoseStorbritannia
-
Memorial Sloan Kettering Cancer CenterExelixisFullførtResidiverende eller refraktært myelomatoseForente stater
-
Hospital Universitario Dr. Jose E. GonzalezFullførtLymfom | Myelom multippelMexico
-
Maastricht University Medical CenterFullførtLymfom | Myelom multippelNederland
-
PfizerAktiv, ikke rekrutterendeMultippelt myelom | Refraktært myelomatose | Myelom | Tilbakefallende myelomatose | Elranatamab | PF-06863135 | BCMA | Bispesifikk | Bispesifikt antistoff | BCMA-CD3 Bispesifikk | MagnetisMM-8Kina
-
National Cancer Institute (NCI)AvsluttetStadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Janssen Research & Development, LLCRekrutteringResidiverende eller refraktært myelomatoseTyskland, Korea, Republikken, Italia, Frankrike, Japan, Israel, Belgia, Danmark, Sverige, Kina, Spania, Tsjekkia, Polen, Australia, Nederland, Argentina, Canada, Storbritannia, Hellas, Brasil, India